INNOVIVA, INC. Share-based Payment Arrangement, Amount Capitalized
INNOVIVA, INC. (INVA) reported Share-based Payment Arrangement, Amount Capitalized of $78.00 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Notes › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2014-08-07
- INNOVIVA, INC. share-based payment arrangement, amount capitalized for the quarter ending 2014-06-30 was $78.00K, a 178.57% increase year-over-year.
- INNOVIVA, INC. share-based payment arrangement, amount capitalized for the quarter ending 2013-12-31 was $30.00K, a 85.15% decline year-over-year.
- INNOVIVA, INC. share-based payment arrangement, amount capitalized for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- INNOVIVA, INC. share-based payment arrangement, amount capitalized for the quarter ending 2013-06-30 was $28.00K.
- INNOVIVA, INC. share-based payment arrangement, amount capitalized for fiscal 2013 was $200.00K, a 50.00% decline from fiscal 2012.
- INNOVIVA, INC. share-based payment arrangement, amount capitalized for fiscal 2012 was $400.00K.
- INNOVIVA, INC. share-based payment arrangement, amount capitalized for fiscal 2011 was $0.00.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2014-06-30 | $78.00K 10-Q · filed 2014-08-07 | $95.00K 10-Q · filed 2014-08-07 | ||
| 2013-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $30.00K derived: sum of 2 quarters · filed 2014-03-03 | $58.00K derived: sum of 3 quarters · filed 2014-08-07 | $200.00K 10-K · filed 2014-03-03 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $28.00K derived: sum of 2 quarters · filed 2014-08-07 | $170.00K 10-Q · filed 2013-11-01 | $330.00K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-06-30 | $28.00K 10-Q · filed 2014-08-07 | $170.00K 10-Q · filed 2014-08-07 | $330.00K derived: sum of 3 quarters · filed 2014-08-07 | $528.00K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $100.00K 10-Q · filed 2014-05-07 | $302.00K derived: sum of 2 quarters · filed 2014-05-07 | $500.00K derived: sum of 3 quarters · filed 2014-05-07 | $500.00K derived: sum of 4 quarters · filed 2014-05-07 |
| 2012-12-31 | $202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $400.00K derived: sum of 2 quarters · filed 2014-03-03 | $400.00K derived: sum of 3 quarters · filed 2014-03-03 | $400.00K 10-K · filed 2014-03-03 |
| 2012-09-30 | $198.00K 10-Q · filed 2013-11-01 | $198.00K derived: sum of 2 quarters · filed 2013-11-01 | $198.00K 10-Q · filed 2013-11-01 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-01 | $0.00 10-Q · filed 2013-08-01 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-01 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |